Logo1
DMAA: The Forum 08
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
Overall quality of the conference.
The program was relevant to my work.
Content matched stated objectives.

Program materials were relevant and accurate.

Usefulness of presentations.

Comfort of rooms.

Facilities and/or technological equipment.
Please rate the expertise of the speaker(s) - Caryn Ireland and Victor J. Strecher.
Please rate the expertise of the speaker(s) - Kejian Niu.
How well did the educational sessions give a balanced view of therapeutic options, including the use of general names?

If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:

Please rate the expertise of the speaker(s) - Ian Duncan.
Please rate the expertise of the speaker(s) - Thomas Kotsos, Antonio P. Linares.
Please rate the expertise of the speaker(s) - Herman Jenich, Kejian Niu.
Please rate the expertise of the speaker(s) - Paul Medrek, Steven M. Schwartz.
Please rate the expertise of the speaker(s) -Jason G. Cooper, Geraldine McNamara
Please rate the expertise of the speaker(s) - J. Ramsay Farah, Thomas C. Messer.
Please rate the expertise of the speaker(s) - Mark A. Johnson.
Please rate the expertise of the speaker(s) - Mark A. Johnson.
Please rate the expertise of the speaker(s) - Elaine Mischler.
Please rate the expertise of the speaker(s) - John Mastrojohn III.
Please rate the expertise of the speaker(s) - John Mastrojohn III.
Please rate the expertise of the speaker(s) - Susan W. Butterworth.
Please rate the expertise of the speaker(s) - Susan W. Butterworth.
Please rate the expertise of the speaker(s) - Wanda Hanson.
Please rate the expertise of the speaker(s) - Wanda Hanson.
Please rate the expertise of the speaker(s) - Peter Boland.
Please rate the expertise of the speaker(s) - John Charde, Dirk Wales.
Please rate the expertise of the speaker(s) - Thomas Kline, Randall E. Williams.
Please rate the expertise of the speaker(s) - Kevin J. Wildenhaus and Wendy Vida.
Please rate the expertise of the speaker(s) - Katie Wreed Bell and Amy Neftzger.
Please rate the expertise of the speaker(s) - Maureen Lillis and Neil Oktavec.
Please rate the expertise of the speaker(s) - Peter C. Dandalides and Jen Clair.
Please rate the expertise of the speaker(s) - Dennis Freeman and Adrienne Mims.
Please rate the expertise of the speaker(s) - Michael P. Blasius; Thomas Hudler and Ruth Philipp.
Please rate the expertise of the speaker(s) - Paul Terry and Donna Shenoha.
Please rate the expertise of the speaker(s) - Neil Goldfarb.
Please rate the expertise of the speaker(s) - F. Douglas Carr, Randall E. Williams.
Please rate the expertise of the speaker(s) - Adam J. Falk, Dee J. Warrington.
Please rate the expertise of the speaker(s) - David Brumley and Philip Renner.
Please rate the expertise of the speaker(s) - Claudia L. Schur.
Please rate the expertise of the speaker(s) - Craig Nelson.
Please rate the expertise of the speaker(s) - David Kelley; Teri Green and Michelle Harker.
Please rate the expertise of the speaker(s) - Craig F. Nelson, Jennifer Pitts, Philip Renner.
Please rate the expertise of the speaker(s) - Rebecca J. Cunningham, Allison McDonough.
Please rate the expertise of the speaker(s) - Vincent T. Kuraitis and R. Steven Adams.
Please rate the expertise of the speaker(s) - Christobel E. Selecky.
Please rate the expertise of the speaker(s) - Rachel La Croix, Amy Neftzger, Claudia L. Schur and Stacy K. Brinkley.
Please rate the expertise of the speaker(s) - Jason G. Cooper.
Please rate the expertise of the speaker(s) - Elaine Mischler.
Please rate the expertise of the speaker(s) - Former US Senator Louisiana John Breaux and Gail Wilensky, PhD.
Please rate the expertise of the speaker(s) - Richard C Bedrosian and Neil Oktavec.
Please rate the expertise of the speaker(s) - KheSahn Barker and David Costello.
Please rate the expertise of the speaker(s) - Andrea Humphrey.
Please rate the expertise of the speaker(s) - Adam Hobgood.
Please rate the expertise of the speaker(s) - Sharon Glave Frazee, PhD.
Please rate the expertise of the speaker(s) - David Costello and Betsy Barbeau.
Please rate the expertise of the speaker(s) - David Brumley.
Please rate the expertise of the speaker(s) - George Oestreich and David Rogers.
Please rate the expertise of the speaker(s) - George Oestreich and David Rogers.
Please rate the expertise of the speaker(s) - Lisa Latts, Jaan Sidorov and Paul J. Wallace.
Please rate the expertise of the speaker(s) - Adam Hobgood.
Objective: Discuss technological advances and trends in information technology such as interactive personal health records and mobile communication.
The above objective will increase my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
Please rate the teaching ability of the speaker(s) - Caryn Ireland and Victor J. Strecher.
Please rate the teaching ability of the speaker(s) - Kejian Niu.
Please rate the teaching ability of the speaker(s) - Ian Duncan.
Please rate the teaching ability of the speaker(s) - Thomas Kotsos, Antonio P. Linares.
Please rate the teaching ability of the speaker(s) - Herman Jenich, Kejian Niu.
Please rate the teaching ability of the speaker(s) - Paul Medrek, Steven M. Schwartz.
Please rate the teaching ability of the speaker(s) - Jason G. Cooper, Geraldine McNamara.
Please rate the teaching ability of the speaker(s) - J. Ramsay Farah, Thomas C. Messer.
Please rate the teaching ability of the speaker(s) - Mark A. Johnson.
Please rate the teaching ability of the speaker(s) - Mark A. Johnson.
Please rate the teaching ability of the speaker(s) - Elaine Mischler.
Please rate the teaching ability of the speaker(s) - John Mastrojohn III.
Please rate the teaching ability of the speaker(s) - John Mastrojohn III.
Please rate the teaching ability of the speaker(s) - Susan W. Butterworth.
Please rate the teaching ability of the speaker(s) - Susan W. Butterworth.
Please rate the teaching ability of the speaker(s) - Wanda Hanson.
Please rate the teaching ability of the speaker(s) - Wanda Hanson.
Please rate the teaching ability of the speaker(s) - Peter Boland.
Please rate the teaching ability of the speaker(s) - John Charde, Dirk Wales.
Please rate the teaching ability of the speaker(s) - Thomas Kline, Randall E. Williams.
Please rate the teaching ability of the speaker(s) - Kevin J. Wildenhaus and Wendy Vida.
Please rate the teaching ability of the speaker(s) - Katie Wreed Bell and Amy Neftzger.
Please rate the teaching ability of the speaker(s) - Maureen Lillis and Neil Oktavec.
Please rate the teaching ability of the speaker(s) - Peter C. Dandalides and Jen Clair.
Please rate the teaching ability of the speaker(s) - Dennis Freeman and Adrienne Mims.
Please rate the teaching ability of the speaker(s) - Michael P. Blasius; Thomas Hudler and Ruth Philipp.
Please rate the teaching ability of the speaker(s) - Paul Terry and Donna Shenoha.
Please rate the teaching ability of the speaker(s) - Neil Goldfarb.
Please rate the teaching ability of the speaker(s) - F. Douglas Carr, Randall E. Williams.
Please rate the teaching ability of the speaker(s) - Adam J. Falk, Dee J. Warrington.
Please rate the teaching ability of the speaker(s) - David Brumley and Philip Renner.
Please rate the teaching ability of the speaker(s) - Claudia L. Schur.
Please rate the teaching ability of the speaker(s) - Craig Nelson.
Please rate the teaching ability of the speaker(s) - David Kelley; Teri Green and Michelle Harker.
Please rate the teaching ability of the speaker(s) - Craig F. Nelson, Jennifer Pitts, Philip Renner.
Please rate the teaching ability of the speaker(s) - Rebecca J. Cunningham, Allison McDonough.
Please rate the teaching ability of the speaker(s) - Vincent T. Kuraitis and R. Steven Adams.
Please rate the teaching ability of the speaker(s) - Christobel E. Selecky.
Please rate the teaching ability of the speaker(s) - Rachel La Croix, Amy Neftzger, Claudia L. Schur and Stacy K. Brinkley.
Please rate the teaching ability of the speaker(s) - Jason G. Cooper.
Please rate the teaching ability of the speaker(s) - Elaine Mischler.
Please rate the teaching ability of the speaker(s) - Former US Senator Louisiana John Breaux and Gail Wilensky, PhD.
Please rate the teaching ability of the speaker(s) - Richard C Bedrosian and Neil Oktavec.
Please rate the teaching ability of the speaker(s) - KheSahn Barker and David Costello.
Please rate the teaching ability of the speaker(s) - Andrea Humphrey.
Please rate the teaching ability of the speaker(s) - Adam Hobgood.
Please rate the teaching ability of the speaker(s) - Sharon Glave Frazee, PhD.
Please rate the teaching ability of the speaker(s) - David Costello and Betsy Barbeau.
Please rate the teaching ability of the speaker(s) - David Brumley.
Please rate the teaching ability of the speaker(s) - George Oestreich and David Rogers.
Please rate the teaching ability of the speaker(s) - George Oestreich and David Rogers.
Please rate the teaching ability of the speaker(s) - Lisa Latts, Jaan Sidorov and Paul J. Wallace.
Please rate the teaching ability of the speaker(s) - Adam Hobgood.
Objective: Evaluate various care delivery models in Medicare, Medicaid and other public programs that have made a mark on care quality, participant satisfaction and financial outcomes.
The above objective will increase my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Please rate the organization of materials.

Objective: Describe how care management leaders have leveraged technology and responded with innovative solutions to meet emerging demands in the marketplace, such as pricing transparency and end-of-life care.
The above objective will increase my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.

List the methodological challenges and potential solutions for rigorously demonstrating risk and cost reduction in a “naturalistic” setting.

Describe how a wellness and disease prevention program can produce positive outcomes for large health plan population.
Discuss the criteria used to evaluate outlier identification and treatment methods.
Discuss the effectiveness of various outlier identification and treatment methods.
Discuss opportunities for enhancing wellness and disease prevention initiatives with online interventions.
Define the recommended outlier solution and its key assumptions.
Discuss the value of health risk assessments data to explain health care claim costs.
Quantify costs and changes in cost associated with health risk assessment attributes as a basis for making savings estimates.
Identify a method for prioritizing members for interventions.
Identify the five most costly low back pain related medical services.
Evaluate the utilization factors that contribute to increased duration of narcotic analgesic usage for individuals with low back pain.
Examine a method for classifying individuals with low back pain into clinically meaningful diagnostic criteria for outcomes research.
Compare historical chronic and non-chronic trends and how to adjust for the current year non-chronic trend.
Identify the methods used to test the trend assumptions.
Analyze the results and its implications for trend adjustment using the DMAA recommended method.
Discuss the role of key behavioral drivers of impaired productivity and the implications for delivering services and cutting costs.
Discuss the concept of independent risks for productivity impairment.
Describe how productivity impairment can be monetized in such a way as to inform the allocation of health resources based on expected returns.
Describe how innovative clinical metric development contributes to expanding the disease management vendor and health plan relationship to drive change across the continuum of care.
Discuss surveillance and intervention strategies.
Cite the ACR guidelines for DMARDs in RA and glucocorticoid-induced osteoporosis.
Discuss random fluctuations, validity and appropriate truncation in measuring disease management effectiveness.
Distinguish the minimum sample size and confidence intervals to demonstrate program savings.
Demonstrate the use of a simple model for determining validity of program savings.
Discuss value models and return on investment (ROI) calculations.
Analyze primary results from landmark trials.
Identify differences in RPM systems and disease management programs.
Discuss value models and return on investment (ROI) calculations.
Analyze primary results from landmark trials.
Identify differences in RPM systems and disease management programs.
Discuss the final report.
Discuss the size of the industry, performance of disease management and wellness programs.
Discuss future growth plans and industry trends.
Describe how hospice and palliative care services fit into the care continuum.
Identify triggers for referral to hospice and palliative care.
Review strategies used by health insurance plans and other health care providers to educate their members and patients about end-of-life care issues.
Describe how hospice and palliative care services fit into the care continuum.
Identify triggers for referral to hospice and palliative care.
Review strategies used by health insurance plans and other health care providers to educate their members and patients about end-of-life care issues.
Define the role that different outreach efforts and incentives play in increasing recruitment in interventions at the worksite.
Analyze the difference between impact and efficacy as they relate to cost-effectiveness of health management interventions at the worksite.
Identify the attributes of two successful health promotion interventions that significantly lower risk factors and increase productivity at the worksite.
Define the role that different outreach efforts and incentives play in increasing recruitment in interventions at the worksite.
Analyze the difference between impact and efficacy as they relate to cost-effectiveness of health management interventions at the worksite.
Identify the attributes of two successful health promotion interventions that significantly lower risk factors and increase productivity at the worksite.
Define the advanced medical home.
Dsicuss the advanced medical home model of care delivery at a health system.
Discuss the advanced medical home’s impact on quality outcomes and financial outcomes.
Define the advanced medical home.
Dsicuss the advanced medical home model of care delivery at a health system.
Discuss the advanced medical home’s impact on quality outcomes and financial outcomes.
Define the role of software applications that run on cell phones to increase the effectiveness and efficiency of disease management.
Describe how patients with diabetes can benefit from an integrated approach of case management and wireless technology to decrease their risk factors and better manage their condition.
Identify the behavioral elements necessary to engage patients and increase their adherence to medical regimens.
Identify the special needs of this population.
Identify and use clinical outcome measures that are most important to this group.
Cite interventions that save significant dollars, reduce overall cost and improve quality of life.
Discuss engagement and retention activities targeted to unique behavioral segments to enhance recruitment into programs.
Describe how communications technologies, coupled with behavioralist trained staff, can augment programs’ reach and effectiveness.
State the key insights around Medicaid and Medicare member recruitment and retention.
Define the role of self-management interventions to compliment traditional disease managment approaches.
Identify three key components of an effective self-management program.
Discuss 90-day outcomes on nine critical components of effective chronic illness self-management.
Discuss an unprecedented index on well-being, which provides a daily pulse and long-term trends on the health of individuals, communities and companies across the United States.
Describe the new understandings of what creates well-being derived from 1,000 daily interviews with individuals.
Discuss future implications of the index findings over the next 25 years, ranging from correlations between work and community environment and overall health, benchmarking opportunities for well-being and health comparisons.
Describe the impact of co-morbid conditions on elderly populations.
Identify the correlation between acute and chronic care needs for optimal outcomes.
Identify obstacles to successful care management in home and community based settings.
Identify the key drivers of a member enrolling, defined as getting the member’s permission to participate, in the disease management program upon contact.
Explain the drivers of engaging, defined as a nurses assessing a member’s health and well-being, previously enrolled members in a program once they speak to a nurse.
Discuss how these findings are being applied to the enrollment and engagement processes to enhance engagement outcomes.
Explain the impact of co-occurring behavioral health with medical conditions on life expectancy.
Evaluate the pros and cons of integrated care models.
Identify resources to address the critical factors for success.
Identify ways to improve, measure and translate clinical outcomes into economic benefit.
Discuss two case studies that advanced population-based care through both conventional and cutting-edge techniques.
Discuss German telemedicine programs for patients with congestive heart failure that reduced hospital stays by 48 percent, total costs by 39.5 percent (6,993 Euros per patient) and mortality rates by 46 percent
Identify the best practices in worksite health promotion.
Discuss program components that yield the highest participant engagement rates and the most dramatic reductions in population-level health risks.
Discuss a healthy weight program designed for individuals struggling with weight at all points along the continuum.
Examine current policies regarding obesity management, decision-maker knowledge regarding obesity impact and treatment effectiveness, and attitudes toward expanding coverage in light of the obesity epidemic.
Review the baseline and post-education survey findings.
Discover implications for future efforts to design and implement obesity management policies and programs.
Compare the differences and similarities between vendor-based disease management and provider-driven disease management.
Discuss how provider-based Medicare demonstrations are delivering breakthrough levels of improvement in utilization and quality.
Describe how disease management programs might better engage Medicare members by better engaging the member’s physicians.
Discuss legal risks and what constitutes a violation.
Identify key risk areas for disease management companies.

Describe features of an effective corporate comliance program.

Identify and prioritize metrics for evaluating obesity care.
Review of the literature, treatment algorithms and existing measures, the feasibility of nationally standardized performance measures was assessed.

Discuss the process of identifying performance measures and assessing feasibility, opportunities for improvement in obesity assessment and treatment and the levels of health care system accountability for improving care.

Discuss the findings of the physician focus groups.
Describe the physicians perspectives of disease management programs in relation to their practices.

Discuss the development of the actual survey instrument.

Discuss one approach to assessing the return on investment of a program based on modeling the effects of risk factor changes on medical claims costs.

Evaluate an obesity management program that provides telephonic counseling, educational resources and web-based tracking resources.

Discuss diet, exercise and stress management.

Discuss Pay for Performance/Pay for Participation (P4P) programs.

Describe how P4P programs were implemented and outcomes achieved in two different state Medicaid environments.

Define a wellness program, a program impact model and a series of guiding principals for evaluating a wellness program.

Discuss project synergies, as well as the broader applications to the industry.

Define integration points between providers and disease management.

Discuss identification and implementation of successful strategies.
Review results of successful integration strategies.

Discuss the emerging personal health information ecosystem and explain why it is potentially disruptive to existing disease management business models.

Define the role of large, non-healthcare companies (Google, Microsoft, Dossia, Intel, Wal-Mart and others) in this marketspace.
List specific actions disease management players can take to be leaders in advancing interoperability.

Identify which techniques can be helpful to improve enrollment and engagement rates in a Medicare fee-for-service population.

Describe how to interpret results for enrollment and engagement.
Explain how to implement findings.

Discuss the survey and usage guidelines.

Explain targeting a population, sampling, methodology and response rate information.
Identify the potential implications for poor adherence to pharmacotherapy.
Explain the methods used to tackle the tasks of measurement methodology for medication adherence.
Discuss potential confounders, validation testing results and next steps to consider for 2009 efforts.
Discuss the final report.
Discuss the size of the industry, performance of disease management and wellness programs.
Discuss future growth plans and industry trends.
Describe how a new administration and Congress might respond to a growing prevalence of chronic disease.
Discuss a timely outlook for health care reform, federal health initiatives and prevention, wellness and chronic disease management.
Describe the increasing fiscal constraints and other challenges facing the nation's health care system.
Identify the impact of behavioral health problems on medical outcomes, health care costs and productivity.
Explain how one employer used Internet tools to identify those with behavioral health problems and provide them with interventions.
Review the outcome data resulting from the deployment of these screening tools and interventions.
Establish a multicultural program using a community segment framework.
Identify targeted populations by integrating third party information, claims or HRAs generated data.
Develop performance metrics that measure member reach and engage rates.

Discuss the strengths and weaknesses of various obesity prevention models demonstrate why multipartner, multilevel programs are a critical future approach.

Review current and past intervention models used to address the obesity epidemic, including individual-level and family-level behavioral interventions, school-based interventions, community-based interventions and policy and environmental changes.

Discover the ways in which disease management components can enhance program results, along with policy changes needed to ensure the success of next generation obesity prevention programs.

Identify the limitations of self-reported HRAs in identifying patients for care management programs.
Describe the relationship between biometric risk scores and employee productivity.
Describe the alternatives to exclusive use of self-reported HRAs for identification of high risk employees.
Discuss the impact employers can play in providing a medical home and why it is not only “doing good”, but good business, to do this.
Describe the effectiveness of an innovative strategy to improve engagement and retention of participants in disease management programs.
Recognize the benefits of integrating the “trusted clinician” at the workplace to create a medical home and enhance the value of population health improvement programs.

Describe a predictive model that leverages third-party demographic and consumer data to more effectively identify and target members for health and wellness outreach interventions.

Discuss consumer-centric data elements to develop health and wellness proxies and the use of third-party data for health and wellness risk identification in the absence of, or in combination with, claims and HRA data.
Explain how to develop and leverage health and wellness proxy measures to assist in the outreach targeting and measurement efforts.

Discuss a common clinical framework for improving chronic illness care.

Describe a flexible and adaptable model for use in other settings.
Identify key factors to deliver successful outcomes.

Discuss how to improve the quality of care, decrease complications and control costs for Medicaid beneficiaries with chronic illnesses.

Discuss how cohort analysis of participants with 12 months consecutive enrollment demonstrated favorable impact in utilization and costs from program inception.
Describe how increased engagement with primary care providers and community health centers through provider decision support and pay-for-performance support chronic care improvement for this vulnerable low-income population.

Discuss how to improve the quality of care, decrease complications and control costs for Medicaid beneficiaries with chronic illnesses.

Discuss how cohort analysis of participants with 12 months consecutive enrollment demonstrated favorable impact in utilization and costs from program inception.
Describe how increased engagement with primary care providers and community health centers through provider decision support and pay-for-performance support chronic care improvement for this vulnerable low-income population.
Identify the limitations of self-reported HRAs in identifying patients for care management programs.
Describe the relationship between biometric risk scores and employee productivity.
Describe the alternatives to exclusive use of self-reported HRAs for identification of high risk employees.
Discuss approaches to integrating population health improvement into the patient-centered medical home.

Discuss organizations that are developing solutions today in collaboration with primary care practices.

Explore the successful fit of population-based strategies in the medical home from the perspective of health plans, Medicaid programs, disease management organizations and integrated health systems.

Objective: Explore effective strategies for engaging program participants and providers that improve enrollment and adherence to care management, including the context of difficult-to-reach populations and multiple care settings.
The above objective will increase my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
If you have additional comments regarding the session or speaker(s), please use the space below:
Objective: Discuss the role of population health improvement in the patient-centered medical home model to coordinated care, successful collaborations already undersay and the implications for chronic condition prevention and management.
The above objective will increase my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
Objective: Explore international efforts to advance population-based care through both conventional and cutting-edge techniques.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
Objective: Review key issues in outcomes measurement, one of the most-talked-about subjects in chronic disease prevention and care.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
Objective: Identify effective methods of treating and preventing obesity and associated co-morbidities.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
Objective: Explore the integration of wellness, prevention and chronic disease management initiatives in the workplace and how it provides the multiple "touch points" critical to engaging employees in health promotion initiatives.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
Objective: Discuss how successful market leaders make disease prevention and management an integral part of their corporate culture.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
Objective: Describe how corporate leaders employ a variety of approaches and tools, such as health screenings, to generate employee engagement in wellness and diseease management effrorts.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
Objective: Discuss the construction and analysis of risk adjuster studies, predictive modeling basics (including the generalized linear model) and two-part and longitudinal models for use in modeling care utilization.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in changes to performance in my professional practice.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?

Do you believe this activity will result in your ability to improve your professional practice or organization?

Was the ecducational content scientifically sound?
Was the educational content free of commercial bias?
If faculty spoke about off-label or investigational use of a product, was that information disclosed to you?
Was the mode of education effective to learning?
Was the time allotted to the learning activity appropriate?

If applicable, were prerequisites appropriate?

If you answered 'No' to any of the above questions, please explain:
Were you solicited by sales personnel in an educational room while you attended this educational activity?
If you answered 'Yes' to the above question, please explain:
What did you learn during this activity that you intend to integrate into your practice or organization?

List any perceived practice "gaps" (educational needs/topics) which you would like to see the focus of future trainings.

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training be improved to impact your organization or practice?

Do you have additional comments about the conference?  We encourage you to provide both positive and negative comments.

Only Florida licensees need to answer this question.  Notice to Florida Licensees:  In order for us to report your hours to CE Broker, you MUST provide us with your Florida alpha-numeric license number (e.g., PY1234, SS123, MH1234, MT1234).  Please be sure you enter this number accurately, or CE Broker will not record your hours.
Mr question